Search research articles
Contact Us
Filters
Showing results (541-550 of 556) with videos related to
Page
of 56
Sort By:
Blood Advances
|
September 13, 2021
Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy
David A Bond, Jeffrey M Switchenko, Diego Villa, et al.
The Journal of Pediatrics
|
September 14, 2024
Impact of Elevated Serum Triglycerides on Children with Acute Recurrent or Chronic Pancreatitis from INSPPIRE-2
Zachary M Sellers, Matthew J Giefer, Fuchenchu Wang, et al.
Blood Advances
|
December 14, 2022
Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma
Narendranath Epperla, Jeffrey Switchenko, Veronika Bachanova, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 16, 2026
Pancreatitis Risk Genes Play a Major Role in Pediatric Pancreatitis: Insights From INSPPIRE
Maisam Abu-El-Haija, Wenying Zhang, Fuchenchu Wang, et al.
Vaccine
|
December 8, 2022
Added value of the measles-rubella supplementary immunization activity in reaching unvaccinated and under-vaccinated children, a cross-sectional study in five Indian districts, 2018-20
C Prosperi, J W V Thangaraj, A Z Hasan, et al.
Blood Advances
|
May 28, 2025
Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR
Kitsada Wudhikarn, Megan M Herr, Min Chen, et al.
Journal of Hematology & Oncology
|
July 16, 2022
Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study
Narendranath Epperla, Qiuhong Zhao, Sayan Mullick Chowdhury, et al.
Blood Neoplasia
|
March 23, 2026
Impact of age on outcomes after CD19 CAR T-cell therapy for large B-cell lymphomas
Abu-Sayeef Mirza, Chitra Hosing, Francine Foss, et al.
Blood
|
July 15, 2025
Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab
Taylor R Brooks, Emily C Zabor, Yohanna Bedelu, et al.
Blood Advances
|
October 21, 2022
Postibrutinib relapse outcomes for patients with marginal zone lymphoma
Narendranath Epperla, Qiuhong Zhao, Sayan Mullick Chowdhury, et al.
Page
of 56
Search research articles
Search
Showing results (541-550 of 556) with videos related to
Sort By:
Page
of 56
Blood Advances
|
September 13, 2021
Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy
David A Bond, Jeffrey M Switchenko, Diego Villa, et al.
The Journal of Pediatrics
|
September 14, 2024
Impact of Elevated Serum Triglycerides on Children with Acute Recurrent or Chronic Pancreatitis from INSPPIRE-2
Zachary M Sellers, Matthew J Giefer, Fuchenchu Wang, et al.
Blood Advances
|
December 14, 2022
Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma
Narendranath Epperla, Jeffrey Switchenko, Veronika Bachanova, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
June 16, 2026
Pancreatitis Risk Genes Play a Major Role in Pediatric Pancreatitis: Insights From INSPPIRE
Maisam Abu-El-Haija, Wenying Zhang, Fuchenchu Wang, et al.
Vaccine
|
December 8, 2022
Added value of the measles-rubella supplementary immunization activity in reaching unvaccinated and under-vaccinated children, a cross-sectional study in five Indian districts, 2018-20
C Prosperi, J W V Thangaraj, A Z Hasan, et al.
Blood Advances
|
May 28, 2025
Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTR
Kitsada Wudhikarn, Megan M Herr, Min Chen, et al.
Journal of Hematology & Oncology
|
July 16, 2022
Predictive factors and outcomes for ibrutinib in relapsed/refractory marginal zone lymphoma: a multicenter cohort study
Narendranath Epperla, Qiuhong Zhao, Sayan Mullick Chowdhury, et al.
Blood Neoplasia
|
March 23, 2026
Impact of age on outcomes after CD19 CAR T-cell therapy for large B-cell lymphomas
Abu-Sayeef Mirza, Chitra Hosing, Francine Foss, et al.
Blood
|
July 15, 2025
Real-world outcomes of patients with aggressive B-cell lymphoma treated with epcoritamab or glofitamab
Taylor R Brooks, Emily C Zabor, Yohanna Bedelu, et al.
Blood Advances
|
October 21, 2022
Postibrutinib relapse outcomes for patients with marginal zone lymphoma
Narendranath Epperla, Qiuhong Zhao, Sayan Mullick Chowdhury, et al.
Page
of 56